Fig. 1From: Real-world burden of adverse events for apalutamide- or enzalutamide-treated non-metastatic castration-resistant prostate cancer patients in the United StatesDistribution of included patients. Abbreviations: AE, adverse event; ARI, androgen receptor inhibitor; nmCRPC, non-metastatic castrate-resistant prostate cancerBack to article page